Abstract
The possibility of using VEGF-R1 receptor for targeted therapy in oncology was investigated. Using the approach to measuring the protein content in intact nuclei of cells, which was developed by us, we showed the presence of this receptor in the nuclei of tumor, but not normal cells. A direct correlation between the level of VEGF-R1 expression in the nucleus and the degree of malignancy of tumor cells, indicating the prognostic value of this parameter, was found. The mechanisms of the functioning of this receptor and the pathways of inhibiting its activity are discussed, and the validity of the selection of VEGF-R1 as a molecular target for anticancer therapy is conformed.
Similar content being viewed by others
References
Fan, F., Wey, J.S., McCarty, M.F., et al., Oncogen, 2005, vol. 24, pp. 2647–2653.
Wey, J.S., Fan, F., Gray, M.J., et al., Cancer, 2005, vol. 104, pp. 427–438.
Lee, T.-H., Seng, S., Sekine, M., et al., PLoS Medicine, 2007, vol. 4, no. 6, pp. 1001–1016.
Bhattacharya, R., Ye, X.C., Wang, R., et al., Cancer Res., 2016, vol. 76, no. 10, pp. 3014–3024. doi: 10.1158/0008-5472.CAN-15-1605
Tyrsina, E.G., Nikulitskii, S.I., Inshakov, A.N., and Ryabaya, O.O., Onkoginekologiya, 2016, no. 2, pp. 13–21.
Nikulitskii, S.I., Tyrsina, E.G., Inshakov, A.N., and Borovkova, N.B., Ross. Bioterapevt. Zh., 2016, no. 2, pp. 75–80.
Szabo, E., Schneider, H., Seystahl, K., et al., Neuro Oncol., 2016, no. 9, pp. 1242–1252. doi: 10.1093/neuonc/now043
Vincent, L., Jin, D.K., Karajannis, M.A., et al., Cancer Res., 2005, vol. 65, pp. 3185–3192.
Owen, L.A., Uehara, H., Cahoon, J., et al., PLoS ONE, 2013, vol. 7, no. 3, p. e33576.
Broers, J.L.V. and Ramaekers, F.C.S., Adv. Exp. Med. Biol., 2014, vol. 773, pp. 27–48. doi 10.1007/978-1-4899-8032-8_2.2. PMID:24563342
Chen, M.-K. and Hung, M.-C., Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases, FEBS J., 2015, vol. 282, no. 19, pp. 3693–3721. doi 10.1111/febs.13342
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E.G. Tyrsina, S.I. Nikulitskiy, A.N. Inshakov, O.O. Ryabaya, 2018, published in Doklady Akademii Nauk, 2018, Vol. 478, No. 2, pp. 236–239.
Rights and permissions
About this article
Cite this article
Tyrsina, E.G., Nikulitskiy, S.I., Inshakov, A.N. et al. VEGF-R1 as a Potential Molecular Target for Anticancer Therapy. Dokl Biochem Biophys 478, 18–20 (2018). https://doi.org/10.1134/S1607672918010052
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1607672918010052